Debt-to-equity of ESSA Pharma Inc. from 30 Jun 2021 to 30 Jun 2025

Taxonomy & unit
ratio: %
Description
Debt-to-equity (D/E) ratio is used to evaluate a company's financial leverage and is calculated by dividing a company's total liabilities by its shareholder equity.
Summary
ESSA Pharma Inc. quarterly Debt-to-equity in % history and change rate from 30 Jun 2021 to 30 Jun 2025.
  • ESSA Pharma Inc. Debt-to-equity for the quarter ending 30 Jun 2025 was 2.3%, a 18% decline year-over-year.
Debt-to-equity, Quarterly (%)
Debt-to-equity, YoY Quarterly Change (%)

ESSA Pharma Inc. Quarterly Debt-to-equity (%)

Period Value YoY Chg Change % Date
Q2 2025 2.3% -0.5% -18% 30 Jun 2025
Q1 2025 2.7% +0.03% +1.1% 31 Mar 2025
Q4 2024 3.1% +0.91% +42% 31 Dec 2024
Q3 2024 3% +0.98% +50% 30 Sep 2024
Q2 2024 2.8% +1.1% +64% 30 Jun 2024
Q1 2024 2.7% +0.88% +49% 31 Mar 2024
Q4 2023 2.2% +0.2% +10% 31 Dec 2023
Q3 2023 2% -0.08% -3.9% 30 Sep 2023
Q2 2023 1.7% -0.48% -22% 30 Jun 2023
Q1 2023 1.8% -0.3% -14% 31 Mar 2023
Q4 2022 2% -0.13% -6.2% 31 Dec 2022
Q3 2022 2% -0.14% -6.4% 30 Sep 2022
Q2 2022 2.2% +0.09% +4.3% 30 Jun 2022
Q1 2022 2.1% 31 Mar 2022
Q4 2021 2.1% 31 Dec 2021
Q3 2021 2.2% 30 Sep 2021
Q2 2021 2.1% 30 Jun 2021
* An asterisk sign (*) next to the value indicates that the value is likely invalid.